PHI with Endangiitis obliterans
How does this condition affect your private health insurance?
Endangiitis obliterans, or Buerger's disease, is a rare, non-atherosclerotic inflammatory vasculitis primarily affecting small and medium-sized arteries and veins in the extremities. Almost exclusively found in heavy smokers, particularly young males, it causes segmental thrombosis and occlusion of blood vessels, leading to severe ischemia. Symptoms include intermittent claudication, Raynaud's phenomenon, migratory superficial thrombophlebitis, and eventually chronic rest pain, ischemic ulcers, and gangrene. Without complete smoking cessation, the condition relentlessly progresses, often necessitating amputations of digits or limbs. Its exact cause is unknown but is critically linked to tobacco, causing significant morbidity and disability.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months, with progressive ischemic symptoms like claudication or Raynaud's phenomenon.
Duration of Illness (Lifetime)
Chronic and progressive if tobacco use continues; potentially lifelong with residual damage even after cessation.
Cost of Treatment (Initial)
Moderate to high, including diagnostic tests, medication, wound care, pain management, and potential short-term hospitalization.
Cost of Treatment (Lifetime)
Very high, often involving long-term medication, frequent wound care, repeated hospitalizations, reconstructive surgeries, and potentially multiple amputations.
Mortality Rate
Low directly, but complications such as severe infections following amputations or generalized cardiovascular events (common in smokers) can increase long-term mortality risk.
Risk of Secondary Damages
Very high: severe chronic pain, ischemic ulcers, gangrene, digit and limb amputations, disability, reduced quality of life, and significant psychological distress.
Probability of Full Recovery
Very low. While smoking cessation can halt disease progression, existing vascular damage and tissue loss are generally irreversible, leading to permanent consequences.
Underlying Disease Risk
Not typically associated with other specific autoimmune or systemic diseases as a cause, but strongly and almost exclusively linked to tobacco use and its associated cardiovascular risk factors.